Prognostic performance of pre-treatment NLR and PLR in patients suffering from osteosarcoma

被引:0
作者
Wen-Kai Xia
Zhi-Li Liu
Dong Shen
Qing-Feng Lin
Jun Su
Wei-Dong Mao
机构
[1] The Affiliated Jiangyin Hospital of Southeast University Medical College,Department of Nephrology
[2] The Affiliated Jiangyin Hospital of Southeast University Medical College,Department of Oncology
来源
World Journal of Surgical Oncology | / 14卷
关键词
Osteosarcoma; NLR; PLR; Prognosis;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [41] Prognostic value of pre-treatment F-18-FDG PET-CT in patients with hepatocellular carcinoma undergoing radioembolization
    Yazan Abuodeh
    Arash O Naghavi
    Kamran A Ahmed
    Puja S Venkat
    Youngchul Kim
    Bela Kis
    Junsung Choi
    Benjamin Biebel
    Jennifer Sweeney
    Daniel A Anaya
    Richard Kim
    Mokenge Malafa
    Jessica M Frakes
    Sarah E Hoffe
    Ghassan El-Haddad
    World Journal of Gastroenterology, 2016, (47) : 10406 - 10414
  • [42] Pre-treatment systemic immune-inflammation index is a useful prognostic indicator in patients with breast cancer undergoing neoadjuvant chemotherapy
    Chen, Li
    Kong, Xiangyi
    Wang, Zhongzhao
    Wang, Xiangyu
    Fang, Yi
    Wang, Jing
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2020, 24 (05) : 2993 - 3021
  • [43] Prognostic value of pre-treatment F-18-FDG PET-CT in patients with hepatocellular carcinoma undergoing radioembolization
    Abuodeh, Yazan
    Naghavi, Arash O.
    Ahmed, Kamran A.
    Venkat, Puja S.
    Kim, Youngchul
    Kis, Bela
    Choi, Junsung
    Biebel, Benjamin
    Sweeney, Jennifer
    Anaya, Daniel A.
    Kim, Richard
    Malafa, Mokenge
    Frakes, Jessica M.
    Hoffe, Sarah E.
    El-Haddad, Ghassan
    WORLD JOURNAL OF GASTROENTEROLOGY, 2016, 22 (47) : 10406 - 10414
  • [44] Exploratory Evaluation of Pre-Treatment Inflammation Profiles in Patients with Colorectal Cancer
    Feier, Catalin Vladut Ionut
    Muntean, Calin
    Bolboaca, Sorana D.
    Olariu, Sorin
    DISEASES, 2024, 12 (03)
  • [45] Low miR-34a and miR-192 are associated with unfavorable prognosis in patients suffering from osteosarcoma
    Wang, Yuan
    Jia, Lian-Shun
    Yuan, Wen
    Wu, Zhao
    Wang, Hai-Bo
    Xu, Tao
    Sun, Jing-Chuan
    Cheng, Ke-Fu
    Shi, Jian-Gang
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2015, 7 (01): : 111 - 119
  • [46] Prognostic relevance of pre-treatment inflammatory biomarkers along with other clinicopathological and treatment factors in oral cavity cancers
    Kothandaraman, Shri Kamakshi
    Krishnamurthy, Arvind
    Mittal, Saket
    Ramshankar, Vijayalakshmi
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2023, 19 (SUPPL 1) : S212 - S221
  • [47] Pre-treatment red blood cell distribution width provides prognostic information in multiple myeloma
    Zhou, Di
    Xu, Peipei
    Peng, Miaoxin
    Shao, Xiaoyan
    Wang, Miao
    Ouyang, Jian
    Chen, Bing
    CLINICA CHIMICA ACTA, 2018, 481 : 34 - 41
  • [48] The Prognostic Model of Pre-Treatment Complete Blood Count (CBC) for Recurrence in Early Cervical Cancer
    Noh, Joseph J.
    Lim, Myong Cheol
    Kim, Moon-Hong
    Kim, Yun Hwan
    Song, Eun Seop
    Seong, Seok Ju
    Suh, Dong Hoon
    Lee, Jong-Min
    Lee, Chulmin
    Choi, Chel Hun
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (09) : 1 - 13
  • [49] Pre-treatment platelet counts as a prognostic and predictive factor in stage II and III rectal adenocarcinoma
    Steele, Morgan
    Voutsadakis, Ioannis A.
    WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2017, 9 (01) : 42 - 49
  • [50] Pre-treatment lymphocytopaenia is an adverse prognostic biomarker in muscle-invasive and advanced bladder cancer
    Joseph, N.
    Dovedi, S. J.
    Thompson, C.
    Lyons, J.
    Kennedy, J.
    Elliott, T.
    West, C. M.
    Choudhury, A.
    ANNALS OF ONCOLOGY, 2016, 27 (02) : 294 - 299